:: Volume 27, Issue 2 (summer 2017) ::
MEDICAL SCIENCES 2017, 27(2): 113-118 Back to browse issues page
Anticancer effects of some Girard-P reagent-based schiff bases and ‎their Dimethyltin (IV) complexes on malignant glioblastoma cell line ‎in in vitro culture
Elham Hoveizi1 , Zynab Ansariasl2
1- Department of Biology, Faculty of Sciences, Shahid Chamran University of Ahvaz, Ahvaz, Iran
2- Department of Chemistry, College of Science, Shahid Chamran University of Ahvaz, Ahvaz, Iran
Abstract:   (6269 Views)
Background: Glioblastoma (U-87) is the most common and most malignant of the glial tumors that ‎appeared in the central nervous system. This is the first study that has evaluated the cytotoxic effects ‎of various Girard-P reagent-based Schiff bases and their dimethyltin (IV) complexes on Glioblastoma ‎cell line, U-87, viability. ‎ Materials and methods: In this experimental study, U-87 cell line was grown in DMEM ‎supplemented with 10% FBS, penicillin/streptomycin (100 U/ml, 100 µg/ml) at 37 ◦C in 5% CO2, then ‎the effects of different concentrations of complexes on Glioblastoma cell were evaluated by MTT and ‎DAPI staining. ‎ Results: Herein, we demonstrated that these compounds had cytotoxicity effects of Glioblastoma ‎cancer cells. In a dose dependent manner, a significant cytotoxicity was observed with increasing of ‎P1M and P3. ‎ Conclusion: The results showed that Girard-P reagent-based Schiff bases and their dimethyltin (IV) ‎complexes have the ability to induce cytotoxicity in the Glioblastoma cancer cell line in lower mg/ml ‎concentrations. In conclusion, these findings may introduce a new view on the mode of action and ‎possible application of new compounds in the cancer chemotherapy.‎ Keywords: Cancer, Schiff bases, Dimethyltin (IV) Complexes, U-87‎
Keywords: Cancer, Schiff bases, Dimethyltin (IV) Complexes, U-87‎
Full-Text [PDF 194 kb]   (2081 Downloads)    
Semi-pilot: Experimental | Subject: Animal Biology
Received: 1901/12/14 | Accepted: 2017/03/6 | Published: 2017/06/19


XML   Persian Abstract   Print



Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 27, Issue 2 (summer 2017) Back to browse issues page